risedronate (Actonel)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

* bone loss after discontinuation of therapy may be greater for risedronate than alendronate or zoledronate[9]

Tabs: 5 mg, 35 mg for weekly dosing, 75 mg, 150 mg

Adverse effects

Mechanism of action

More general terms

Additional terms

Component of

References

  1. The Prescriber's Letter, vol 6 #11, Nov 1999
    The Prescriber's Letter, vol 7 #5, May 2000
  2. Journal Watch, Mass Med Soc 19(23):183 (Dec) 1999
  3. Journal Watch, Mass Med Soc 19(24):190 (Dec) 1999
  4. Kaiser Permanente Northern California Regional Drug Formulary, Update 9/99
  5. Prescriber's Letter 7(8):47 2000
    Prescriber's Letter 9(6):31 2002
  6. 6.0 6.1 Prescriber's Letter 10(8):47 2003
  7. Department of Veterans Affairs, VA National Formulary
  8. 8.0 8.1 Prescriber's Letter 14(6): 2007 New Developments With Bisphosphonate Therapy Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230613&pb=PRL (subscription needed) http://www.prescribersletter.com
  9. 9.0 9.1 9.2 Whitaker M et al Bisphosphonates for Osteoporosis - Where Do We Go from Here? N Engl J Med 2012 May 9, <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22571168 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMp1202619
    Black DM et al Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long? N Engl J Med 2012 May 9, <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/22571169 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMp1202623
  10. 10.0 10.1 Reid IR Efficacy, effectiveness and side effects of medications used to prevent fractures. J Intern Med. 2015 Jun;277(6):690-706 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25495429

Database